MedTrace Logo

Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors

NCT02006563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2017-10-24

No results posted yet for this study

Summary

* Metabolic Tumor Volume (MTV), identified by Magnetic Resonance Spectroscopic Imaging (MRSI) is different from the Clinical Target Volume (CTV) used for radiation dose delivery in the treatment of brain tumors.
* If MTV \> CTV, the investigators hypothesize that the difference in volumes (cc) is related to worse clinical outcome. Furthermore, in case of local recurrence, the lesion is located in the MTV area that is outside of the CTV.
* Alternatively, if CTV \> MTV, then the difference in volumes is related to higher treatment toxicity.

Conditions

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Radka Stoyanova, PhD · University of Miami

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-08
Primary Completion
2016-01-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02006563 on ClinicalTrials.gov